Kobo Biotech Ltd Share Price

₹2.41 0.00 (0.00%) BSE
as updated on 02-Apr-2026 16:59 | Sector - Healthcare

Day Range

  • Day's Low:0.00
  • Day's High:0.00

  • 52 Week Low1.99
  • 52 Week High3.58

Kobo Biotech Ltd's key Fundamentals

Market Cap ₹6 Cr.
P/E Ratio 0
TTM EPS -2.1
P/B Ratio 0.00
ROE 4.13
Debt to Equity -1.09
Face Value 10
BVPS 0
3 Year Sales Growth 0.00%

Kobo Biotech Ltd's Share Price Returns

1 Day 0.00%
1 Week 8.10%
1 Month 3.40%
3 Months 1.30%
6 Months 4.80%
1 Years -23.20%
3 Years 14.80%
5 Years -65.50%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Kobo Biotech Ltd Shareholding Pattern

Promoters

(44.95%)

Institutions

(0.00%)

Non-Institutions

(55.05%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Kobo Biotech Ltd

AVON Organics Limited (AOL) was started by P R Agarwal, Rajesh Agarwal along with late G S Sidhu .It is located at Madhupala Towers Greenlands, Hyderabad 500 016, India. The company's transition from a machinery manufacturer to a full-fledged chemical manufacturer saw the company foraying into the highly technology-intensive area of Diketene and its derivatives.

In the year 1996 the company established and successfully commissioned its first grass root Diketene plant .It has doubled its production capacity by commissioning an additional 1000 TPA unit as part of its second phase in 1998.  It is an ISO 9000 certification by the Lloyds Register Quality Assurance (LRQA).

Business profile:

A keen insight and a well-planned development process saw AOL discover the opportunity in the production of Diketene - the basic unit for hundreds of derivatives in pesticides, chemicals, pharmaceuticals and dyestuffs. A highly classified technology, it has been sourced from Shanghai Peng Pu Chemical Works, China, and Xytel Technology Partnership, USA, and now rests in the hands of a few chosen manufacturers across the globe.

The company, with its immense infrastructure framework has introduced modifications to the Chinese technology and has a current production of 3000 tonnes per annum against an installed capacity of 2000 tonnes per annum. A sprawling facility of 21 acres, the plant is situated 60 kilometers from Hyderabad. The locale is ideal due to its easy connectivity made possible by the well-traversed National Highway # 9 that links Hyderabad with Mumbai.

Products :

  • Diketene:
  • Pharmaceutical intermediates
  • Agrochemical intermediates
  • Pigment intermediates 

Pharmaceutical (Including Ephedrines) :

  • Active Pharmaceutical ingredients
  • Pharma intermediates
  • Formulation intermediates 
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 0.00
  • Day's High: 0.00

  • 52 Week Low1.99
  • 52 Week High3.58

Kobo Biotech Ltd's key Fundamentals

Market Cap ₹6 Cr.
P/E Ratio 0
TTM EPS -2.1
P/B Ratio 0.00
ROE 4.13
Debt to Equity -1.09
Face Value 10
BVPS 0
3 Year Sales Growth 0.00%

Kobo Biotech Ltd's Share Price Returns

1 Day 0.00%
1 Week 8.10%
1 Month 3.40%
3 Months 1.30%
6 Months 4.80%
1 Years -23.20%
3 Years 14.80%
5 Years -65.50%
10 Years 0%

Investment related blogs

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×